Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Angelman Syndrome | 22 | 2024 | 139 | 6.860 |
Why?
|
Developmental Disabilities | 12 | 2024 | 1518 | 1.010 |
Why?
|
Ubiquitin-Protein Ligases | 7 | 2020 | 1901 | 0.990 |
Why?
|
Genetic Diseases, Inborn | 4 | 2021 | 606 | 0.860 |
Why?
|
Basal Cell Nevus Syndrome | 1 | 2021 | 38 | 0.750 |
Why?
|
Child Development | 3 | 2024 | 2330 | 0.740 |
Why?
|
Genomic Imprinting | 5 | 2022 | 326 | 0.720 |
Why?
|
Tooth, Supernumerary | 1 | 2020 | 7 | 0.710 |
Why?
|
Prader-Willi Syndrome | 3 | 2021 | 81 | 0.710 |
Why?
|
Hamartoma Syndrome, Multiple | 2 | 2014 | 115 | 0.690 |
Why?
|
Levodopa | 2 | 2017 | 221 | 0.660 |
Why?
|
Birth Order | 1 | 2019 | 93 | 0.660 |
Why?
|
Stereotyped Behavior | 1 | 2019 | 133 | 0.630 |
Why?
|
Congenital Abnormalities | 2 | 2021 | 703 | 0.620 |
Why?
|
Siblings | 2 | 2019 | 828 | 0.610 |
Why?
|
Codon, Initiator | 1 | 2018 | 50 | 0.610 |
Why?
|
Maple Syrup Urine Disease | 1 | 2018 | 41 | 0.600 |
Why?
|
Esophageal Atresia | 1 | 2020 | 226 | 0.560 |
Why?
|
Chromosomes, Human, Pair 15 | 5 | 2022 | 361 | 0.560 |
Why?
|
Ataxia | 4 | 2020 | 307 | 0.560 |
Why?
|
Conserved Sequence | 1 | 2020 | 1162 | 0.540 |
Why?
|
Abnormalities, Multiple | 4 | 2020 | 1424 | 0.540 |
Why?
|
Carcinoma, Basal Cell | 1 | 2021 | 565 | 0.520 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2018 | 249 | 0.500 |
Why?
|
Epilepsy | 8 | 2021 | 3327 | 0.480 |
Why?
|
Activities of Daily Living | 1 | 2024 | 2429 | 0.480 |
Why?
|
Nervous System | 1 | 2018 | 544 | 0.480 |
Why?
|
Muscle Hypotonia | 2 | 2020 | 166 | 0.470 |
Why?
|
Microcephaly | 3 | 2015 | 426 | 0.450 |
Why?
|
Phenotype | 22 | 2021 | 16723 | 0.420 |
Why?
|
Prenatal Diagnosis | 1 | 2020 | 1275 | 0.420 |
Why?
|
Ocular Motility Disorders | 1 | 2014 | 144 | 0.410 |
Why?
|
Infant | 31 | 2024 | 36534 | 0.400 |
Why?
|
Mutation | 23 | 2022 | 30211 | 0.400 |
Why?
|
Repressor Proteins | 2 | 2020 | 2982 | 0.380 |
Why?
|
Child, Preschool | 31 | 2024 | 42665 | 0.380 |
Why?
|
Pancreatitis | 1 | 2018 | 1087 | 0.370 |
Why?
|
Genetic Loci | 1 | 2020 | 2629 | 0.350 |
Why?
|
Motor Skills | 3 | 2024 | 523 | 0.350 |
Why?
|
Child | 36 | 2024 | 80906 | 0.340 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2014 | 386 | 0.340 |
Why?
|
Growth Disorders | 1 | 2015 | 635 | 0.340 |
Why?
|
Sulfite Oxidase | 2 | 2006 | 10 | 0.330 |
Why?
|
Chromosome Aberrations | 3 | 2011 | 1777 | 0.320 |
Why?
|
DNA Mutational Analysis | 4 | 2018 | 4114 | 0.320 |
Why?
|
Brain Diseases, Metabolic, Inborn | 2 | 2006 | 46 | 0.310 |
Why?
|
Genetic Association Studies | 6 | 2022 | 2744 | 0.300 |
Why?
|
PTEN Phosphohydrolase | 2 | 2014 | 1120 | 0.260 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 2 | 2006 | 283 | 0.260 |
Why?
|
Cockayne Syndrome | 1 | 2005 | 20 | 0.250 |
Why?
|
Infant Mortality | 2 | 2021 | 752 | 0.250 |
Why?
|
Genotype | 11 | 2021 | 13042 | 0.240 |
Why?
|
Craniosynostoses | 2 | 2022 | 415 | 0.230 |
Why?
|
Arteriovenous Fistula | 1 | 2007 | 320 | 0.220 |
Why?
|
Age of Onset | 3 | 2021 | 3347 | 0.220 |
Why?
|
Heart Defects, Congenital | 1 | 2020 | 4713 | 0.210 |
Why?
|
Isoxazoles | 2 | 2023 | 233 | 0.210 |
Why?
|
Pediatrics | 1 | 2018 | 3629 | 0.210 |
Why?
|
Epilepsy, Generalized | 2 | 2022 | 181 | 0.200 |
Why?
|
Humans | 69 | 2024 | 767991 | 0.200 |
Why?
|
Pedigree | 6 | 2021 | 4539 | 0.190 |
Why?
|
Vital Statistics | 1 | 2021 | 31 | 0.190 |
Why?
|
Blood Vessels | 1 | 2007 | 1110 | 0.190 |
Why?
|
Primary Health Care | 1 | 2018 | 4746 | 0.190 |
Why?
|
Hereditary Sensory and Autonomic Neuropathies | 1 | 2021 | 41 | 0.180 |
Why?
|
Infant, Newborn | 12 | 2021 | 26420 | 0.180 |
Why?
|
Intensive Care, Neonatal | 1 | 2002 | 200 | 0.180 |
Why?
|
Adolescent | 19 | 2024 | 89155 | 0.180 |
Why?
|
Male | 41 | 2024 | 364641 | 0.180 |
Why?
|
DNA-Binding Proteins | 4 | 2020 | 9614 | 0.180 |
Why?
|
GABA Agonists | 1 | 2020 | 106 | 0.180 |
Why?
|
Dentin | 1 | 2020 | 75 | 0.170 |
Why?
|
Optic Atrophy | 1 | 2020 | 79 | 0.170 |
Why?
|
Rett Syndrome | 1 | 2021 | 164 | 0.170 |
Why?
|
Brain Diseases | 2 | 2019 | 1554 | 0.160 |
Why?
|
Ectodermal Dysplasia | 1 | 2020 | 107 | 0.160 |
Why?
|
Mandibular Condyle | 1 | 2020 | 118 | 0.160 |
Why?
|
Databases, Genetic | 2 | 2020 | 1758 | 0.160 |
Why?
|
Vancomycin | 1 | 2002 | 504 | 0.160 |
Why?
|
Co-Repressor Proteins | 1 | 2020 | 190 | 0.160 |
Why?
|
Beckwith-Wiedemann Syndrome | 1 | 2019 | 45 | 0.160 |
Why?
|
Nerve Tissue Proteins | 2 | 2021 | 4414 | 0.150 |
Why?
|
Thioredoxins | 1 | 2019 | 202 | 0.150 |
Why?
|
Cardiac Myosins | 1 | 2018 | 128 | 0.150 |
Why?
|
Language Development Disorders | 2 | 2018 | 194 | 0.150 |
Why?
|
GABA Plasma Membrane Transport Proteins | 1 | 2018 | 30 | 0.150 |
Why?
|
Female | 38 | 2024 | 397113 | 0.150 |
Why?
|
Carrier Proteins | 2 | 2021 | 4937 | 0.140 |
Why?
|
Marfan Syndrome | 1 | 2019 | 237 | 0.140 |
Why?
|
Epilepsies, Myoclonic | 1 | 2018 | 85 | 0.140 |
Why?
|
Myosin Heavy Chains | 1 | 2018 | 404 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 7 | 2020 | 18062 | 0.140 |
Why?
|
Chromosome Deletion | 4 | 2017 | 1384 | 0.140 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2017 | 180 | 0.140 |
Why?
|
Genetic Testing | 4 | 2020 | 3589 | 0.130 |
Why?
|
Oligoribonucleotides, Antisense | 1 | 2016 | 14 | 0.130 |
Why?
|
Topoisomerase Inhibitors | 1 | 2016 | 19 | 0.130 |
Why?
|
Young Adult | 11 | 2024 | 60048 | 0.130 |
Why?
|
Myokymia | 1 | 2015 | 11 | 0.130 |
Why?
|
Hyperkinesis | 1 | 2016 | 88 | 0.130 |
Why?
|
Long-Term Potentiation | 1 | 2017 | 290 | 0.130 |
Why?
|
Chromosome Disorders | 2 | 2019 | 498 | 0.130 |
Why?
|
Kv1.1 Potassium Channel | 1 | 2015 | 31 | 0.130 |
Why?
|
Pyrroline Carboxylate Reductases | 1 | 2015 | 6 | 0.130 |
Why?
|
Chorea | 1 | 2016 | 80 | 0.120 |
Why?
|
Amino Acid Transport Systems, Acidic | 1 | 2015 | 30 | 0.120 |
Why?
|
Cataplexy | 1 | 2015 | 62 | 0.120 |
Why?
|
Hereditary Central Nervous System Demyelinating Diseases | 1 | 2015 | 44 | 0.120 |
Why?
|
Cleft Lip | 1 | 2020 | 512 | 0.120 |
Why?
|
Minocycline | 1 | 2016 | 170 | 0.120 |
Why?
|
Transcription Factors | 4 | 2022 | 12165 | 0.120 |
Why?
|
Mitochondrial Proteins | 1 | 2020 | 979 | 0.120 |
Why?
|
Early Diagnosis | 1 | 2019 | 1193 | 0.120 |
Why?
|
Cleft Palate | 1 | 2020 | 596 | 0.120 |
Why?
|
Brain Waves | 1 | 2019 | 417 | 0.120 |
Why?
|
Psychomotor Disorders | 1 | 2015 | 149 | 0.120 |
Why?
|
Medical History Taking | 1 | 2018 | 779 | 0.110 |
Why?
|
Esophagus | 1 | 2020 | 1042 | 0.110 |
Why?
|
Trachea | 1 | 2020 | 1095 | 0.110 |
Why?
|
Antiporters | 1 | 2015 | 276 | 0.110 |
Why?
|
Glucuronosyltransferase | 1 | 2014 | 136 | 0.110 |
Why?
|
Bayes Theorem | 1 | 2021 | 2358 | 0.110 |
Why?
|
Protein Isoforms | 1 | 2018 | 1715 | 0.110 |
Why?
|
Disease Management | 2 | 2021 | 2533 | 0.110 |
Why?
|
Musculoskeletal Abnormalities | 1 | 2014 | 101 | 0.110 |
Why?
|
Bone Diseases, Developmental | 1 | 2014 | 132 | 0.110 |
Why?
|
Parenting | 1 | 2019 | 708 | 0.100 |
Why?
|
Fetus | 1 | 2020 | 1884 | 0.100 |
Why?
|
Longitudinal Studies | 2 | 2024 | 14783 | 0.100 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2012 | 66 | 0.100 |
Why?
|
Wilms Tumor | 1 | 2015 | 378 | 0.100 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1793 | 0.100 |
Why?
|
Retrospective Studies | 12 | 2021 | 81746 | 0.100 |
Why?
|
Facies | 3 | 2020 | 224 | 0.100 |
Why?
|
Physical Examination | 1 | 2018 | 1263 | 0.100 |
Why?
|
Adult | 16 | 2024 | 223583 | 0.100 |
Why?
|
PAX2 Transcription Factor | 1 | 2012 | 86 | 0.100 |
Why?
|
Down Syndrome | 1 | 2020 | 919 | 0.100 |
Why?
|
Hyperventilation | 1 | 2011 | 78 | 0.100 |
Why?
|
Cerebellar Cortex | 1 | 2012 | 108 | 0.100 |
Why?
|
Coloboma | 1 | 2012 | 60 | 0.090 |
Why?
|
Dystonic Disorders | 1 | 2016 | 354 | 0.090 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2012 | 149 | 0.090 |
Why?
|
Mitochondrial Diseases | 1 | 2015 | 344 | 0.090 |
Why?
|
Alleles | 2 | 2020 | 6894 | 0.090 |
Why?
|
Syndrome | 4 | 2022 | 3271 | 0.090 |
Why?
|
Ependyma | 1 | 2010 | 57 | 0.090 |
Why?
|
Ultrasonography, Prenatal | 1 | 2019 | 1772 | 0.090 |
Why?
|
Cause of Death | 1 | 2021 | 3720 | 0.090 |
Why?
|
Cell Cycle Proteins | 2 | 2020 | 3443 | 0.090 |
Why?
|
Homozygote | 2 | 2015 | 1778 | 0.090 |
Why?
|
Paraplegia | 1 | 2010 | 161 | 0.080 |
Why?
|
Gene Silencing | 1 | 2016 | 1505 | 0.080 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 706 | 0.080 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2011 | 325 | 0.080 |
Why?
|
Gene Duplication | 2 | 2008 | 315 | 0.080 |
Why?
|
Seizures | 3 | 2022 | 2998 | 0.080 |
Why?
|
Electroencephalography | 6 | 2019 | 6311 | 0.080 |
Why?
|
Sepsis | 1 | 2002 | 2608 | 0.080 |
Why?
|
Sequence Analysis, DNA | 1 | 2019 | 4785 | 0.070 |
Why?
|
Tight Junctions | 1 | 2010 | 324 | 0.070 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2012 | 433 | 0.070 |
Why?
|
Fatal Outcome | 2 | 2019 | 1836 | 0.070 |
Why?
|
DNA Methylation | 3 | 2022 | 4426 | 0.070 |
Why?
|
Uniparental Disomy | 2 | 2022 | 46 | 0.070 |
Why?
|
Deep Brain Stimulation | 1 | 2016 | 851 | 0.070 |
Why?
|
Mice | 4 | 2020 | 82024 | 0.070 |
Why?
|
Disease Models, Animal | 2 | 2017 | 18344 | 0.070 |
Why?
|
Cardiomyopathies | 1 | 2018 | 2057 | 0.070 |
Why?
|
Health Care Costs | 1 | 2019 | 3239 | 0.070 |
Why?
|
DNA Helicases | 1 | 2011 | 854 | 0.070 |
Why?
|
Mitochondria | 1 | 2019 | 3681 | 0.070 |
Why?
|
Melanosis | 1 | 2007 | 93 | 0.060 |
Why?
|
Renal Insufficiency | 1 | 2012 | 812 | 0.060 |
Why?
|
Sequence Deletion | 2 | 2010 | 1494 | 0.060 |
Why?
|
DNA Copy Number Variations | 1 | 2014 | 2048 | 0.060 |
Why?
|
Case Management | 1 | 2007 | 277 | 0.060 |
Why?
|
Base Pairing | 1 | 2005 | 139 | 0.060 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2863 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3231 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2018 | 3619 | 0.060 |
Why?
|
Mutation, Missense | 3 | 2021 | 2592 | 0.060 |
Why?
|
Kidney | 1 | 2020 | 7065 | 0.060 |
Why?
|
Genomics | 1 | 2021 | 5925 | 0.060 |
Why?
|
Syndactyly | 1 | 2005 | 75 | 0.060 |
Why?
|
Ear | 1 | 2005 | 172 | 0.060 |
Why?
|
Cataract | 1 | 2010 | 837 | 0.060 |
Why?
|
Animals | 6 | 2022 | 169222 | 0.060 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2005 | 348 | 0.060 |
Why?
|
Cell Adhesion Molecules | 1 | 2010 | 1613 | 0.060 |
Why?
|
Neuropsychological Tests | 1 | 2017 | 7140 | 0.060 |
Why?
|
Calcium | 1 | 2017 | 5794 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7445 | 0.060 |
Why?
|
Membrane Proteins | 2 | 2019 | 7876 | 0.060 |
Why?
|
Globus Pallidus | 1 | 2005 | 248 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2014 | 3798 | 0.060 |
Why?
|
Anti-Bacterial Agents | 1 | 2002 | 7470 | 0.060 |
Why?
|
Cerebellar Ataxia | 1 | 2005 | 151 | 0.060 |
Why?
|
Cohort Studies | 6 | 2021 | 41749 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 6 | 2021 | 36742 | 0.050 |
Why?
|
Stress, Psychological | 1 | 2019 | 4530 | 0.050 |
Why?
|
Proteins | 2 | 2010 | 6009 | 0.050 |
Why?
|
Anxiety | 2 | 2022 | 4672 | 0.050 |
Why?
|
Blood Flow Velocity | 1 | 2007 | 1375 | 0.050 |
Why?
|
Nipples | 1 | 2005 | 227 | 0.050 |
Why?
|
Protein Conformation | 2 | 2021 | 3956 | 0.050 |
Why?
|
Methionine | 1 | 2005 | 573 | 0.050 |
Why?
|
Age Factors | 1 | 2019 | 18407 | 0.050 |
Why?
|
Cerebral Cortex | 1 | 2019 | 5813 | 0.050 |
Why?
|
snRNP Core Proteins | 1 | 2022 | 21 | 0.050 |
Why?
|
Autistic Disorder | 2 | 2010 | 1240 | 0.050 |
Why?
|
Scalp | 1 | 2005 | 391 | 0.050 |
Why?
|
Hemangioma | 1 | 2007 | 727 | 0.050 |
Why?
|
Calcinosis | 1 | 2010 | 1481 | 0.050 |
Why?
|
Sodium Channel Blockers | 1 | 2022 | 173 | 0.050 |
Why?
|
Karyotyping | 2 | 2018 | 1176 | 0.050 |
Why?
|
Data Collection | 1 | 2011 | 3326 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2023 | 65364 | 0.050 |
Why?
|
Gene Deletion | 3 | 2019 | 2673 | 0.050 |
Why?
|
Head | 1 | 2007 | 926 | 0.050 |
Why?
|
Pregnancy | 2 | 2020 | 30260 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15944 | 0.050 |
Why?
|
Genome, Human | 2 | 2019 | 4443 | 0.050 |
Why?
|
Neurodegenerative Diseases | 1 | 2010 | 1095 | 0.050 |
Why?
|
Cysteine | 1 | 2005 | 897 | 0.040 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2020 | 42 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 8052 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10757 | 0.040 |
Why?
|
Cerebral Hemorrhage | 1 | 2010 | 2655 | 0.040 |
Why?
|
Beta Rhythm | 1 | 2019 | 65 | 0.040 |
Why?
|
Dietary Supplements | 1 | 2011 | 3445 | 0.040 |
Why?
|
Mosaicism | 1 | 2022 | 480 | 0.040 |
Why?
|
Delta Rhythm | 1 | 2019 | 81 | 0.040 |
Why?
|
Comparative Genomic Hybridization | 2 | 2010 | 474 | 0.040 |
Why?
|
Haploinsufficiency | 1 | 2020 | 334 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2023 | 12464 | 0.040 |
Why?
|
Zinc Fingers | 1 | 2020 | 577 | 0.040 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2021 | 453 | 0.040 |
Why?
|
Quality of Life | 1 | 2019 | 13489 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2011 | 5799 | 0.030 |
Why?
|
Theta Rhythm | 1 | 2019 | 220 | 0.030 |
Why?
|
Inheritance Patterns | 1 | 2018 | 344 | 0.030 |
Why?
|
Mammals | 1 | 2022 | 1136 | 0.030 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2017 | 386 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2006 | 4248 | 0.030 |
Why?
|
Bipolar Disorder | 1 | 2013 | 5130 | 0.030 |
Why?
|
Rare Diseases | 1 | 2021 | 631 | 0.030 |
Why?
|
Middle Aged | 4 | 2021 | 223422 | 0.030 |
Why?
|
Adipose Tissue | 1 | 2007 | 3329 | 0.030 |
Why?
|
Valproic Acid | 1 | 2018 | 444 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2020 | 3055 | 0.030 |
Why?
|
Gene Dosage | 1 | 2019 | 1211 | 0.030 |
Why?
|
Checklist | 1 | 2022 | 842 | 0.030 |
Why?
|
United Arab Emirates | 1 | 2014 | 42 | 0.030 |
Why?
|
Bone Marrow Neoplasms | 1 | 2015 | 101 | 0.030 |
Why?
|
Mental Disorders | 1 | 2014 | 6875 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2012 | 16041 | 0.030 |
Why?
|
Genetic Linkage | 2 | 2012 | 2342 | 0.030 |
Why?
|
Epilepsies, Partial | 1 | 2018 | 435 | 0.030 |
Why?
|
Gestational Age | 1 | 2002 | 3622 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2019 | 2227 | 0.030 |
Why?
|
Neurons | 1 | 2012 | 9518 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4857 | 0.030 |
Why?
|
Brain | 1 | 2019 | 27366 | 0.030 |
Why?
|
Galactosyltransferases | 1 | 2014 | 284 | 0.030 |
Why?
|
Forecasting | 1 | 2021 | 2945 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2015 | 736 | 0.020 |
Why?
|
Cystic Fibrosis | 1 | 2021 | 1294 | 0.020 |
Why?
|
Models, Molecular | 1 | 2021 | 5402 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2012 | 668 | 0.020 |
Why?
|
Proteoglycans | 1 | 2014 | 809 | 0.020 |
Why?
|
Oman | 1 | 2010 | 16 | 0.020 |
Why?
|
Prognosis | 2 | 2022 | 29979 | 0.020 |
Why?
|
Child Language | 1 | 2010 | 62 | 0.020 |
Why?
|
Family | 1 | 2021 | 3210 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2019 | 6071 | 0.020 |
Why?
|
Frameshift Mutation | 1 | 2011 | 392 | 0.020 |
Why?
|
Vesicular Transport Proteins | 1 | 2012 | 377 | 0.020 |
Why?
|
Caregivers | 1 | 2022 | 2302 | 0.020 |
Why?
|
Fibroblasts | 1 | 2019 | 4176 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39345 | 0.020 |
Why?
|
Aged | 1 | 2021 | 171446 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2022 | 3834 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2014 | 936 | 0.020 |
Why?
|
Disease Progression | 1 | 2005 | 13665 | 0.020 |
Why?
|
Anticonvulsants | 1 | 2018 | 1922 | 0.020 |
Why?
|
United States | 3 | 2021 | 73027 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9368 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6786 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 2007 | 1305 | 0.020 |
Why?
|
Echocardiography | 1 | 2018 | 5050 | 0.020 |
Why?
|
Skin | 1 | 2019 | 4503 | 0.020 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2006 | 313 | 0.020 |
Why?
|
Speech Disorders | 1 | 2006 | 179 | 0.020 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2010 | 598 | 0.020 |
Why?
|
Length of Stay | 1 | 2019 | 6495 | 0.020 |
Why?
|
Family Health | 1 | 2010 | 1255 | 0.020 |
Why?
|
Neural Stem Cells | 1 | 2012 | 895 | 0.020 |
Why?
|
Failure to Thrive | 1 | 2005 | 139 | 0.010 |
Why?
|
Toes | 1 | 2005 | 209 | 0.010 |
Why?
|
Genetic Variation | 1 | 2019 | 6611 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2010 | 2357 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2011 | 13000 | 0.010 |
Why?
|
Consanguinity | 1 | 2005 | 460 | 0.010 |
Why?
|
Bone and Bones | 1 | 2014 | 2589 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2012 | 4289 | 0.010 |
Why?
|
Arabs | 1 | 2005 | 190 | 0.010 |
Why?
|
Registries | 1 | 2019 | 8377 | 0.010 |
Why?
|
Genes, Recessive | 1 | 2005 | 625 | 0.010 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2006 | 359 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15867 | 0.010 |
Why?
|
Fingers | 1 | 2005 | 511 | 0.010 |
Why?
|
Psychometrics | 1 | 2011 | 3062 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2005 | 20757 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2010 | 4618 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2012 | 3612 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2019 | 5366 | 0.010 |
Why?
|
Zebrafish | 1 | 2012 | 3036 | 0.010 |
Why?
|
Cytoskeletal Proteins | 1 | 2006 | 1327 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2006 | 2510 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 26375 | 0.010 |
Why?
|
Hospitalization | 1 | 2019 | 10840 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2014 | 9536 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2012 | 10470 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2006 | 3780 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2006 | 2906 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2010 | 12797 | 0.010 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2006 | 2816 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2013 | 12795 | 0.010 |
Why?
|
Cognition | 1 | 2010 | 7072 | 0.010 |
Why?
|
Schizophrenia | 1 | 2010 | 6983 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2007 | 22287 | 0.010 |
Why?
|
Risk Factors | 1 | 2010 | 74936 | 0.000 |
Why?
|